Multiple Sclerosis Home Treatment Equity Act of 1994
Everywhere this bill has been
6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 30, 1994
Referred to the Subcommittee on Health and the Environment.
Jun 27, 1994
Referred to the Subcommittee on Health.
Jun 21, 1994
Referred to the House Committee on Ways and Means.
Jun 21, 1994
Referred to the House Committee on Energy and Commerce.
Jun 21, 1994
Sponsor introductory remarks on measure. (CR E1261)
Jun 21, 1994
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Multiple Sclerosis Home Treatment Equity Act of 1994 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to provide coverage and payment for self-administered betaseron (Interferon beta-1b) for patients with multiple sclerosis.
What's happening now
Referred to the Subcommittee on Health and the Environment.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
4
Cite this page
U.S. Congress. (2026). H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994. 103rd Congress. Open America. https://openamerica.io/bill/103-HR-4610/
"H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-HR-4610/.
H.R. 4610, 103rd Cong. (2026), https://openamerica.io/bill/103-HR-4610/.
[H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994](https://openamerica.io/bill/103-HR-4610/)